Results 221 to 230 of about 12,502 (244)

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

JACC: Heart Failure, 2013
Milton Packer, John R Teerlink, James B Young   +2 more
exaly  

Direct Myocardial Effects of Levosimendan in Humans With Left Ventricular Dysfunction

Circulation, 2007
Michael M Givertz
exaly  

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

Journal of Cardiovascular Pharmacology, 2020
Dominique Bettex, Dulce Brito, Dimitrios Farmakis   +2 more
exaly  

Levosimendan: Molecular mechanisms and clinical implications

International Journal of Cardiology, 2012
Zoltán Papp, Stefan G De Hert, Alexandre Mebazaa   +2 more
exaly  

Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial

Intensive Care Medicine, 2019
David B Antcliffe, Shalini Santhakumaran, Josie K Ward   +2 more
exaly  

Levosimendan and Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia, 2010
DE SANTIS V, VITALE D, TRITAPEPE, Luigi
openaire   +3 more sources

Levosimendan

Reactions Weekly, 2009
openaire   +1 more source

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β‐blockers in SURVIVE†

European Journal of Heart Failure, 2009
Alexandre Mebazaa, John G Cleland
exaly  

Levosimendan

2007
Scott Mercer, Andrew Rhodes
openaire   +1 more source

Furosemide/levosimendan

Reactions Weekly, 2023
openaire   +1 more source